Finn Wislöff

A randomized clinical trial of high‐intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS)

Guido Finazzi, Roberto Marchioli, Vincenzo Brancaccio et al. · Journal of Thrombosis and Haemostasis · 2005 · 587 citations · Full text

Medicine, Hematology, Pharmacotherapy +14

A validated decision model for treating the anaemia of myelodysplastic syndromes with erythropoietin + granulocyte colony‐stimulating factor: significant effects on quality of life

Eva Hellström‐Lindberg, Nina Gulbrandsen, Greger Lindberg et al. · British Journal of Haematology · 2003 · 454 citations · Full text

Medicine, Hematology, Pharmacotherapy +16

Guidelines on the diagnosis and management of multiple myeloma 2005

Alastair G. Smith, Finn Wislöff, Diana Samson · British Journal of Haematology · 2005 · 314 citations

Medicine, Hematology, Good Clinical Practice +13

Impact on survival of high-dose therapy with autologous stem cell support in patients younger than 60 years with newly diagnosed multiple myeloma: a population-based study. Nordic Myeloma Study Group.

Stig Lenhoff, Martin Hjorth, Erik Holmberg et al. · PubMed · 2000 · 312 citations

Medicine, Hematology, Oncology +15

Melphalan and prednisone plus thalidomide or placebo in elderly patients with multiple myeloma

Anders Waage, Peter Gimsing, Peter Fayers et al. · Blood · 2010 · 231 citations · Full text

Medicine, Hematology, Oncology +13